Wednesday, 20 February 2019
Subscribe to our RSS Feed
Subscribe
Want to Receive News & Updates from AHDB?
Stay up to date on the latest information you need to devise benefit designs, make coverage decisions, and further value-based healthcare! Sign up for our newsletter or print publications today by entering your contact information below and clicking "Subscribe".
First Name *
Last Name *
Email Address *
Email Address (Verify) *
We will request your mailing address on the next page.
 
American Health & Drug Benefits
  • Home
  • Issues
    • 2019
      • February 2019 - Vol 12 No 1
    • 2018
      • December 2018 Vol 11, No 9
      • November 2018 Vol 11, No 8
      • October 2018 Vol 11 No 7
      • September 2018 Vol 11, No 6
      • July 2018 - Vol 11 No 5
      • June 2018 - Vol 11 No 4
      • May 2018 - Vol 11 No 3
      • April 2018 - Vol 11 No 2
      • February 2018 - Vol 11 No 1
    • 2017
      • December 2017 - Vol 10 No 9
      • November 2017 - Vol 10 No 8
      • October 2017 - Vol 10 No 7
      • September 2017 - Vol 10 No 6
      • July 2017 - Vol 10 No 5
      • June 2017 - Vol 10 No 4
      • May 2017 - Vol 10 No 3
      • April 2017 - Vol 10 No 2
      • February Vol 10 No 1
    • Issue Archive
    • Value-Based Care in Cardiometabolic Health
  • Categories
  • Special Issues
    • Supplements
    • 2019 Special Issues
      • February 2019 - Vol 12 No 1 Supplement 1: Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective
      • February 2019 - Vol 12 No 1 Supplement 2: Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections
    • Special Issue Archive
  • For Authors
    • Call for Papers
      • Submit a Manuscript
    • Instructions for Authors
    • Join Peer Review
      • Peer Reviewer Application
    • Permissions
  • Media Library
    • Video Library
  • Web Exclusives
    • In the News
    • Drug Updates
    • FDA Approvals, News & Updates
    • Online First
    • Press Releases
    • Conference Correspondent
      • ASH 2018 - CLL
      • ID Week 2018
      • ASH 2017 - CLL
      • ACR 2017 - Rheumatoid Arthritis
      • ASCO 2017 - Chronic Lymphocytic Leukemia
      • ASCO 2017 - Acute Myeloid Leukemia
      • ASH 2016 - Multiple Myeloma
      • ASH 2016 - Chronic Lymphocytic Leukemia
  • About Us
    • About AHDB
      • About Engage HC
    • Contact Us
    • Editorial Policies
    • Peer-Review Process
    • Editorial Board
    • Editorial Process
    • Advertising Contacts
    • Advertising Policy
    • Reprints
    • Glossary

Al B. Benson III, MD, FACP, FASCO

Professor of Medicine
Associate Director for Cooperative Groups
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, IL
Authored Items
Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors
Rajeev Ayyagari, PhD, Maureen Neary, PhD, MS, Shang Li, MS, Ariel Rokito, BS, Hongbo Yang, PhD, Jipan Xie, MD, PhD, Al B. Benson III, MD, FACP, FASCO
November 2017 Vol 10, No 8 in Business, Original Research
Role of NCCN in Integrating Cancer Clinical Practice Guidelines into the Healthcare Debate
Al B. Benson III, MD, FACP, FASCO, Elizabeth Brown, MD
February 2008, Vol 1, No 1 in Business
Last modified: December 4, 2017
  • Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME
  • Home
  • About
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Advertising Policy
Copyright © 2019 Engage Healthcare Communications, LLC. All rights reserved.